Infection News

Results from a retrospective review of patients infected with hepatitis C in childhood revealed that those with perinatal infection developed cirrhosis earlier than other risk groups, according to a recently published study.

FDA Commissioner Scott Gottlieb, MD, has issued a new warning about kratom, stating that the agency found “disturbingly high levels of heavy metals” in 26 kratom products.

SAN FRANCISCO — In this exclusive video perspective from The Liver Meeting 2018, Monica Konerman, MD, director of the Michigan Medicine NAFLD Clinic, discusses results of a study that found opioid use to be twice as common among patients with chronic liver disease compared with other common chronic diseases.

TARGET PharmaSolutions has partnered with Gilead Sciences for the TARGET-NASH observational study of nonalcoholic fatty liver disease and the TARGET-HBV observational study of hepatitis B, according to a press release.

The FDA announced that it has approved Aemcolo for the treatment of travelers’ diarrhea caused by noninvasive Escherichia coli strains in adults.

SAN FRANCISCO — Preemptive administration of pangenotypic direct-acting antiviral therapy resulted in rapid viral suppression of hepatitis C in patients without HCV who received a heart transplantation with an HCV-positive organ, according to data presented at The Liver Meeting 2018.

Physicians and assisting staff who do not wear protective masks during endoscopy are at risk for exposures that could result in the transmission of infectious diseases, according to research published in Gastrointestinal Endoscopy.

SAN FRANCISCO — Despite continued drug use, hepatitis C reinfection rarely occurred in a cohort of patients with HCV who received opioid agonist therapy and were treated for HCV, according to findings presented at The Liver Meeting 2018.

SAN FRANCISCO — Mavyret was highly effective and well-tolerated in patients with chronic hepatitis C genotype 1 who had experience with a combination of Sovaldi, NS5A inhibitor and ribavirin, according to data presented at The Liver Meeting 2018.

SAN FRANCISCO — Starting this weekend, Healio Gastroenterology and Liver Disease will provide live coverage from The Liver Meeting 2018.